372 related articles for article (PubMed ID: 32182145)
21. Improving the reach of vaccines to low-resource regions, with a needle-free vaccine delivery device and long-term thermostabilization.
Chen X; Fernando GJ; Crichton ML; Flaim C; Yukiko SR; Fairmaid EJ; Corbett HJ; Primiero CA; Ansaldo AB; Frazer IH; Brown LE; Kendall MA
J Control Release; 2011 Jun; 152(3):349-55. PubMed ID: 21371510
[TBL] [Abstract][Full Text] [Related]
22. [From basic principles to clinical applications on transcutaneous vaccine].
Okada N
Yakugaku Zasshi; 2013; 133(12):1363-72. PubMed ID: 24292185
[TBL] [Abstract][Full Text] [Related]
23. Biodegradable microneedle patch for delivery of meloxicam for managing pain in cattle.
Castilla-Casadiego DA; Miranda-Muñoz KA; Roberts JL; Crowell AD; Gonzalez-Nino D; Choudhury D; Aparicio-Solis FO; Servoss SL; Rosales AM; Prinz G; Zou M; Zhang Y; Coetzee JF; Greenlee LF; Powell J; Almodovar J
PLoS One; 2022; 17(8):e0272169. PubMed ID: 35917312
[TBL] [Abstract][Full Text] [Related]
24. Long-term protective immunity from an influenza virus-like particle vaccine administered with a microneedle patch.
Quan FS; Kim YC; Song JM; Hwang HS; Compans RW; Prausnitz MR; Kang SM
Clin Vaccine Immunol; 2013 Sep; 20(9):1433-9. PubMed ID: 23863506
[TBL] [Abstract][Full Text] [Related]
25. Recent Advancement of Medical Patch for Transdermal Drug Delivery.
Wong WF; Ang KP; Sethi G; Looi CY
Medicina (Kaunas); 2023 Apr; 59(4):. PubMed ID: 37109736
[TBL] [Abstract][Full Text] [Related]
26. Microneedle patch delivery of influenza vaccine during pregnancy enhances maternal immune responses promoting survival and long-lasting passive immunity to offspring.
Esser ES; Pulit-Penaloza JA; Kalluri H; McAllister D; Vassilieva EV; Littauer EQ; Lelutiu N; Prausnitz MR; Compans RW; Skountzou I
Sci Rep; 2017 Jul; 7(1):5705. PubMed ID: 28720851
[TBL] [Abstract][Full Text] [Related]
27. [Oral vaccination and vaccine-entrapped microparticle delivery system].
Li FQ; Fei YB; Su H; Hu JH
Yao Xue Xue Bao; 2007 Mar; 42(3):245-51. PubMed ID: 17520821
[TBL] [Abstract][Full Text] [Related]
28. Microneedle arrays for vaccine delivery: the possibilities, challenges and use of nanoparticles as a combinatorial approach for enhanced vaccine immunogenicity.
Rodgers AM; Cordeiro AS; Kissenpfennig A; Donnelly RF
Expert Opin Drug Deliv; 2018 Sep; 15(9):851-867. PubMed ID: 30051726
[TBL] [Abstract][Full Text] [Related]
29. Microneedle-mediated delivery of viral vectored vaccines.
Zaric M; Ibarzo Yus B; Kalcheva PP; Klavinskis LS
Expert Opin Drug Deliv; 2017 Oct; 14(10):1177-1187. PubMed ID: 27591122
[TBL] [Abstract][Full Text] [Related]
30. Measles vaccination using a microneedle patch.
Edens C; Collins ML; Ayers J; Rota PA; Prausnitz MR
Vaccine; 2013 Jul; 31(34):3403-9. PubMed ID: 23044406
[TBL] [Abstract][Full Text] [Related]
31. Flexible and Stretchable Microneedle Patches with Integrated Rigid Stainless Steel Microneedles for Transdermal Biointerfacing.
Rajabi M; Roxhed N; Shafagh RZ; Haraldson T; Fischer AC; Wijngaart WV; Stemme G; Niklaus F
PLoS One; 2016; 11(12):e0166330. PubMed ID: 27935976
[TBL] [Abstract][Full Text] [Related]
32. Microneedle-based vaccines.
Prausnitz MR; Mikszta JA; Cormier M; Andrianov AK
Curr Top Microbiol Immunol; 2009; 333():369-93. PubMed ID: 19768415
[TBL] [Abstract][Full Text] [Related]
33. Fabrication of microneedle patches with lyophilized influenza vaccine suspended in organic solvent.
Kim YC; Lee JW; Esser ES; Kalluri H; Joyce JC; Compans RW; Skountzou I; Prausnitz MR
Drug Deliv Transl Res; 2021 Apr; 11(2):692-701. PubMed ID: 33590465
[TBL] [Abstract][Full Text] [Related]
34. Increased immunogenicity of avian influenza DNA vaccine delivered to the skin using a microneedle patch.
Kim YC; Song JM; Lipatov AS; Choi SO; Lee JW; Donis RO; Compans RW; Kang SM; Prausnitz MR
Eur J Pharm Biopharm; 2012 Jun; 81(2):239-47. PubMed ID: 22504442
[TBL] [Abstract][Full Text] [Related]
35. Biocompatible Mater Constructed Microneedle Arrays as a Novel Vaccine Adjuvant- Delivery System for Cutaneous and Mucosal Vaccination.
Wang T; Wang N
Curr Pharm Des; 2015; 21(36):5245-55. PubMed ID: 26412356
[TBL] [Abstract][Full Text] [Related]
36. Alternative Methods of Vaccine Delivery: An Overview of Edible and Intradermal Vaccines.
Criscuolo E; Caputo V; Diotti RA; Sautto GA; Kirchenbaum GA; Clementi N
J Immunol Res; 2019; 2019():8303648. PubMed ID: 30949518
[TBL] [Abstract][Full Text] [Related]
37. Microarray patches enable the development of skin-targeted vaccines against COVID-19.
Korkmaz E; Balmert SC; Sumpter TL; Carey CD; Erdos G; Falo LD
Adv Drug Deliv Rev; 2021 Apr; 171():164-186. PubMed ID: 33539853
[TBL] [Abstract][Full Text] [Related]
38. Opportunities and challenges for commercializing microarray patches for vaccination from a MAP developer's perspective.
Forster A; Junger M
Hum Vaccin Immunother; 2022 Nov; 18(4):2050123. PubMed ID: 35356872
[TBL] [Abstract][Full Text] [Related]
39. Technology update: dissolvable microneedle patches for vaccine delivery.
Rodgers AM; Cordeiro AS; Donnelly RF
Med Devices (Auckl); 2019; 12():379-398. PubMed ID: 31572025
[TBL] [Abstract][Full Text] [Related]
40. End-user acceptability study of the nanopatch™; a microarray patch (MAP) for child immunization in low and middle-income countries.
Guillermet E; Alfa DA; Phuong Mai LT; Subedi M; Demolis R; Giersing B; Jaillard P
Vaccine; 2019 Jul; 37(32):4435-4443. PubMed ID: 30890383
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
